PRISMASATE DIALYSIS SOLUTIONS FOR CONTINUOUS RENAL REPLACEMENT THERAPY
FDA 510(k) clearance K072908 · decided 2008-02-04
Clearance details
- K-number
- K072908
- Device name
- PRISMASATE DIALYSIS SOLUTIONS FOR CONTINUOUS RENAL REPLACEMENT THERAPY
- Applicant
- Gambro Renal Products
- Decision
- Substantially Equivalent
- Date received
- 2007-10-12
- Decision date
- 2008-02-04
- Days to decision
- 115 days
- Clearance type
- Traditional
- Product code
- KPO
- Device class
- 2
- Regulation number
- 876.5820
- Medical specialty
- Gastroenterology, Urology
- Advisory committee
- Gastroenterology, Urology
- Location
- Daytona Beach, FL, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Gambro Renal Products
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
Recalls involving this device
| Record | Firm | Date |
|---|---|---|
| PrismaSate BGK2/0 Dialysis Solution for Continuous Renal Replacement Therapy recall (Z-2049-2016) | Baxter Healthcare Corp. | 2016-06-24 |